Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Intravenous or subcutaenous rituximab for FL in the SABRINA study

Dr Andrew Davies - University of Southampton, Southampton, UK
Intravenous or subcutaenous rituximab for FL in the SABRINA study ( Dr Andrew Davies - University of Southampton, Southampton, UK )
4 Dec 2016

Ibrutinib in CLL: RESONATE and resistance

Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA
Ibrutinib in CLL: RESONATE and resistance ( Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA )
4 Dec 2016

Large granular lymphocyte proliferations in MDS

Dr Christa Roe - H. Lee Moffitt Cancer Center, Tampa, USA
Large granular lymphocyte proliferations in MDS ( Dr Christa Roe - H. Lee Moffitt Cancer Center, Tampa, USA )
4 Dec 2016

Durable remissions with the VcR-CVAD regimen for MCL regardless of age

Dr Julie Chang - University of Wisconsin Hospital and Clinics, Madison, USA
Durable remissions with the VcR-CVAD regimen for MCL regardless of age ( Dr Julie Chang - University of Wisconsin Hospital and Clinics, Madison, USA )
4 Dec 2016

Tailoring therapy for leukaemia patients

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Tailoring therapy for leukaemia patients ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )
3 Dec 2016

TKI cessation for CML patients with deep molecular response: an update from the EURO-SKI trial

Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France
TKI cessation for CML patients with deep molecular response: an update from the EURO-SKI trial ( Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France )
3 Dec 2016

Dose reduction of TKIs for CML patients with deep molecular response

Prof Mhairi Copland - University of Glasgow, Glasgow, UK
Dose reduction of TKIs for CML patients with deep molecular response ( Prof Mhairi Copland - University of Glasgow, Glasgow, UK )
3 Dec 2016

Updates from the EURO-SKI trial of tyrosine kinase cessation

Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France
Updates from the EURO-SKI trial of tyrosine kinase cessation ( Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France )
3 Dec 2016

Incidence and risk factors for central venous catheter related thrombosis in children

Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA
Incidence and risk factors for central venous catheter related thrombosis in children ( Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA )
3 Dec 2016

Novel antibody boosts responses in newly diagnosed AML

Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA
Novel antibody boosts responses in newly diagnosed AML ( Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA )
3 Dec 2016

Vadastuximab talirine in combination for newly diagnosed AML

Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA
Vadastuximab talirine in combination for newly diagnosed AML ( Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA )
3 Dec 2016

Remissions following anti-CD22 CAR therapy in children with relapsed ALL

Dr Terry Fry - National Cancer Institute, Bethesda, USA
Remissions following anti-CD22 CAR therapy in children with relapsed ALL ( Dr Terry Fry - National Cancer Institute, Bethesda, USA )
3 Dec 2016